Subject(s)
Celiac Disease/complications , Intestinal Perforation/etiology , Jejunal Diseases/etiology , Lymphoma, Large B-Cell, Diffuse/complications , Adult , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Celiac Disease/diet therapy , Colectomy , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Diet, Gluten-Free , Disease Susceptibility , Down Syndrome/complications , Doxorubicin/administration & dosage , Humans , Intestinal Perforation/surgery , Jejunal Diseases/surgery , Jejunal Neoplasms/complications , Jejunal Neoplasms/drug therapy , Jejunal Neoplasms/prevention & control , Jejunal Neoplasms/surgery , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/prevention & control , Lymphoma, Large B-Cell, Diffuse/surgery , Male , Positron Emission Tomography Computed Tomography , Prednisone/administration & dosage , Rituximab/administration & dosage , Tomography, X-Ray Computed , Vincristine/administration & dosageABSTRACT
The potential of purple corn color (PCC), a natural anthocyanin, to modify colorectal carcinogenesis was investigated in male F344/DuCrj rats, initially treated with 1,2-dimethylhydrazine (DMH), receiving 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the diet. After DMH initiation, PCC was given at a dietary level of 5.0% in combination with 0.02% PhIP until week 36. No PCC-treatment-related changes in clinical signs, body weight and food consumption were found. Incidences and multiplicities of colorectal adenomas and carcinomas in rats initiated with DMH were clearly increased by PhIP. In contrast, lesion development was suppressed by PCC administration. Furthermore, in the non-DMH initiation groups, induction of aberrant crypt foci by PhIP tended to be decreased by the PCC supplementation. The results thus demonstrate that while PhIP clearly exerts promoting effects on DMH-induced colorectal carcinogenesis, these can be reduced by 5.0% PCC in the diet, under the present experimental conditions.
Subject(s)
Adenocarcinoma/prevention & control , Adenoma/prevention & control , Anthocyanins/pharmacology , Anticarcinogenic Agents/pharmacology , Colorectal Neoplasms/prevention & control , Glucosides/pharmacology , Zea mays/chemistry , 1,2-Dimethylhydrazine/administration & dosage , Adenocarcinoma/chemically induced , Adenocarcinoma, Mucinous/chemically induced , Adenocarcinoma, Mucinous/prevention & control , Adenoma/chemically induced , Administration, Oral , Animals , Anthocyanins/administration & dosage , Anthocyanins/chemistry , Anticarcinogenic Agents/administration & dosage , Body Weight/drug effects , Carcinogens/administration & dosage , Cocarcinogenesis , Colonic Diseases/chemically induced , Colonic Diseases/prevention & control , Colorectal Neoplasms/chemically induced , Drug Administration Schedule , Drug Screening Assays, Antitumor , Glucosides/administration & dosage , Glucosides/chemistry , Hyperplasia , Imidazoles/administration & dosage , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Jejunal Neoplasms/chemically induced , Jejunal Neoplasms/prevention & control , Male , Precancerous Conditions/chemically induced , Precancerous Conditions/prevention & control , Prostatic Neoplasms/chemically induced , Prostatic Neoplasms/prevention & control , Rats , Rats, Inbred F344 , Seminal Vesicles/drug effects , Seminal Vesicles/pathologyABSTRACT
PURPOSE: Captopril, an inhibitor of angiotensin I converting enzyme, has been shown to modify radiation damage and prevent radiation injury of normal tissue in rats and pigs. The present study was carried out to determine whether captopril would reduce radiation changes in the proximal small bowel in mice. METHODS AND MATERIALS: Mice were subjected to whole body irradiation with 9 Gy or 15 Gy. Captopril was administered in drinking water at a regimen of 62.5 mg/kg/day (captopril group I) and 125 mg/kg/day (captopril group II), continuously from 7 days before irradiation to the end of each designed experiment. The jejunal damage was evaluated microscopically by crypt count per circumference and by histologic damage grading. RESULTS: Crypt number in the sham-irradiated control was 133 +/- 6.8/circumference. In both captopril group I and II, crypt numbers and histologic scores were not significantly different from those in the normal group. The 9 Gy and 15 Gy radiation alone groups showed significantly lower crypt counts and histologic scores compared with the sham-irradiated control group (p < 0.05). The groups exposed to 9 Gy radiation plus captopril I and II showed significantly higher crypt counts and lower histologic damage scores on the third day, and lower histologic damage scores on the fifth day compared with the 9 Gy radiation alone group (p < 0.05). The 15 Gy radiation plus captopril I and II groups had significantly higher crypt counts and lower histologic damage scores on the third day than those of the 15 Gy radiation alone group (p < 0.05). All mice of the 15 Gy radiation group succumbed to intestinal radiation death. CONCLUSION: Our results suggest that captopril provides protection from acute radiation damage to the jejunal mucosa in mice.
Subject(s)
Captopril/therapeutic use , Intestinal Mucosa/radiation effects , Jejunum/radiation effects , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/therapeutic use , Animals , Intestinal Mucosa/ultrastructure , Jejunal Neoplasms/etiology , Jejunal Neoplasms/prevention & control , Jejunum/ultrastructure , Male , Mice , Mice, Inbred Strains , Neoplasms, Radiation-Induced/prevention & control , Periodic Acid-Schiff ReactionABSTRACT
The purpose of the present study was to establish the effect of the carcinogen 1,2 dimethylhydrazine on the activities of the jejunal glucosidases and to assess the possible modifying effect of different diets. Two control groups of Wistar albino rats were used - fed standard pellet diet and fed the same diet + 1,2 dimethylhydrazine treatment. Six experimental groups treated with 1,2 dimethylhydrazine were provided. One of them was fed standard diet, containing 30% of wheaten bran and the other 5 groups received high-lipid diets, containing 30% of different fats. The rats were injected subcutaneously once a week for 12 weeks with 20 mg 1,2 dimethylhydrazine/kg b.m. and left for 12 weeks in order to develop a tumor growth. The activities of 5 glucosidases (lactase, maltase, sucrase, palatinase and cellobiase) were determined in homogenates from jejunal mucosa taken near by the tumors and in homogenates from the tumors themselves. An expressed decrease of the jejunal glucosidase activities near the tumors and in the tumors was established. The animals fed 30% wheaten bran diet did not develop tumorigenesis and showed comparatively slight decrease of the enzyme activities. In general, the high-fat regimens did not exert such a preventive effect.